World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 68 1536 1376 777 682 422 13153

Balveen Kaur publications per year

The chart shows the history of publications by Balveen Kaur between 1997 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Balveen Kaur published across 29 years, from 1997 to 2025, averaging 18.3 papers a year. Output peaked at 248 publications in 2023. 20 of the 531 publications appeared in the last two years.

No. of publications
50 100 150 200
Bar chart. Horizontal axis: year, 1997 to 2025. Vertical axis: number of publications, 0 to 248. Peak 248 publications in 2023. 1997: 1 publication 1998: 1 publication 1999: 6 publications 2000: 1 publication 2001: 0 publications 2002: 3 publications 2003: 2 publications 2004: 3 publications 2005: 2 publications 2006: 5 publications 2007: 9 publications 2008: 2 publications 2009: 6 publications 2010: 13 publications 2011: 6 publications 2012: 13 publications 2013: 20 publications 2014: 20 publications 2015: 25 publications 2016: 24 publications 2017: 20 publications 2018: 12 publications 2019: 18 publications 2020: 12 publications 2021: 15 publications 2022: 24 publications 2023: 248 publications 2024: 10 publications 2025: 10 publications
1997 2025

531 publications in total across all disciplines

View publications per year as a table
Balveen Kaur: publications per year, 1997 to 2025
Year Publications
1997 1
1998 1
1999 6
2000 1
2001 0
2002 3
2003 2
2004 3
2005 2
2006 5
2007 9
2008 2
2009 6
2010 13
2011 6
2012 13
2013 20
2014 20
2015 25
2016 24
2017 20
2018 12
2019 18
2020 12
2021 15
2022 24
2023 248
2024 10
2025 10
Total 531
Download as CSV

Balveen Kaur publications per year - data summary

  • Balveen Kaur, a Molecular Biology scholar from Augusta University, has 531 publications recorded across 29 years, from 1997 to 2025.
  • The oldest publication on record dates to 1997 and the most recent to 2025.
  • The most productive year is 2023, with 248 publications.
  • The least productive years with any output are 1997, 1998 and 2000, with 1 publication each.
  • 1 of the 29 years in the span carries no publications at all (2001).
  • The rate of publication averages 18.3 papers per year over the whole span, or 19.0 per year counting only the 28 years with at least one publication.
  • The last 5 years on the chart (2021-2025) hold 307 publications, 58% of the career total.
  • Split into equal eras - 1997-2006: 24 publications (2.4 per year); 2007-2016: 138 publications (13.8 per year); 2017-2025: 369 publications (41.0 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Balveen Kaur publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Balveen Kaur sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 417–426 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 422 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20 422
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Balveen Kaur publication distribution in Molecular Biology in 2026 - data summary

  • The chart plots the publication count of all 3,076 Molecular Biology scientists ranked by Research.com in 2026, grouped into 53 ranges running from 47–56 to 564+ publications.
  • Balveen Kaur, a Molecular Biology scholar from Augusta University, records 422 publications - the 92nd percentile of the discipline.
  • 92% of ranked Molecular Biology scientists score the same or lower than Balveen Kaur, and about 8% score higher.
  • The median of the discipline falls in the 177–186 publications range, and Balveen Kaur ranks above the median.
  • The most crowded range is 117–126 publications, holding 177 scientists (6% of the field).
  • 53% of the field sits in the lowest quarter of the value range (up to 177–186 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 564 publications or more, 100 scientists in all (3% of the field).

Balveen Kaur D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Balveen Kaur sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 68–69 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 68 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97 68
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Balveen Kaur D-index placement in Molecular Biology in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 3,076 Molecular Biology scientists ranked by Research.com in 2026, grouped into 54 ranges running from 40–41 to 145+ D-Index.
  • Balveen Kaur, a Molecular Biology scholar from Augusta University, records 68 D-Index - the 52nd percentile of the discipline.
  • 52% of ranked Molecular Biology scientists score the same or lower than Balveen Kaur, and about 48% score higher.
  • The median of the discipline falls in the 68–69 D-Index range, and Balveen Kaur falls inside that same range.
  • The most crowded range is 64–65 D-Index, holding 131 scientists (4% of the field).
  • 50% of the field sits in the lowest quarter of the value range (up to 66–67 D-Index), so the distribution leans towards the lower end of the scale.
  • The final bar has no upper bound: it groups every scientist with 145 D-Index or more, 100 scientists in all (3% of the field).

Overview

Balveen Kaur is affiliated with Augusta University in the United States and has an extensive academic portfolio primarily focused on biochemistry, genetics, molecular biology, and medicine. Their work spans multiple interconnected subfields, including molecular biology, genetics, immunology, oncology, and epidemiology.

Kaur's research encompasses a variety of significant topics, notably virus-based gene therapy research, CAR-T cell therapy, herpesvirus infections and treatments, interferon and immune responses, cancer research and treatments, RNA interference and gene delivery, as well as viral infectious diseases and gene expression in insects.

Their recent papers highlight a focus on cancer and immunotherapy, with notable publications including:

  • The Notch signaling pathway: a potential target for cancer immunotherapy (2023, Journal of Hematology & Oncology)
  • An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma (2021, Nature Communications)
  • Glioma and temozolomide induced alterations in gut microbiome (2020, Scientific Reports)
  • Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury (2020, Pharmacological Reviews)
  • Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity (2022, Nature Cancer)

Kaur frequently publishes in the following venues:

  • Neuro-Oncology
  • Cancer Research
  • Molecular Therapy - Oncolytics
  • Clinical Cancer Research
  • Neuro-Oncology Advances

Collaboration is an important aspect of Kaur's work. Frequent co-authors include Yoshihiro Otani, Ji Young Yoo, Tae Jin Lee, Bangxing Hong, and Sara A. Murphy. These collaborators have contributed to extensive joint research efforts, reflecting a network of active partnerships.

The scientist's contributions to cancer immunotherapy, oncolytic virotherapy, gene therapy, and molecular targeting strategies establish a strong intersection of molecular biology and clinical approaches aimed at understanding and treating complex diseases.

Best Publications

  • Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population.

    Daniel J. Brat;Amilcar A. Castellano-Sanchez;Stephen B. Hunter;Marcia Pecot

  • Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas

    Unknown

  • Geldanamycin Induces Degradation of Hypoxia-inducible Factor 1α Protein via the Proteosome Pathway in Prostate Cancer Cells

    Nicola J. Mabjeesh;Dawn E. Post;Margaret T. Willard;Balveen Kaur

  • CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.

    Jianfeng Han;Jianhong Chu;Wing Keung Chan;Jianying Zhang

  • Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth.

    Unknown

  • NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.

    Christopher A Alvarez-Breckenridge;Jianhua Yu;Richard Price;Jeffrey Wojton

  • Effect of Tumor Microenvironment Modulation on the Efficacy of Oncolytic Virus Therapy

    Kazuhiko Kurozumi;Jayson Hardcastle;Roopa Thakur;Ming Yang

  • Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.

    Balveen Kaur;Daniel J Brat;Narra S Devi;Erwin G Van Meir

  • Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses.

    Giulia Fulci;Nina Dmitrieva;Davide Gianni;Elisabeth J. Fontana

  • Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma

    Fengting Yan;Lapo Alinari;Mark E. Lustberg;Ludmila Katherine Martin

  • MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme

    Sung Suk Suh;Ji Young Yoo;Gerard J. Nuovo;Young Jun Jeon

  • Extracellular Vesicles and Their Convergence with Viral Pathways

    Thomas Wurdinger;NaTosha N. Gatson;Leonora Balaj;Balveen Kaur

  • Thymoquinone Inhibits Autophagy and Induces Cathepsin-Mediated, Caspase-Independent Cell Death in Glioblastoma Cells

    Unknown

  • Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism

    Balveen Kaur;Sarah M Cork;Eric M Sandberg;Narra S Devi

  • RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21

    Tae Jin Lee;Ji Young Yoo;Dan Shu;Hui Li

  • PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.

    Y. K. Banasavadi-Siddegowda;L. Russell;E. Frair;V. A. Karkhanis

  • Impact of tumor microenvironment on oncolytic viral therapy.

    Unknown

  • Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1

    Jayson Hardcastle;Kazuhiko Kurozumi;Nina Dmitrieva;Martin P Sayers

  • Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.

    Hiroaki Uchida;Hiroaki Uchida;Marco Marzulli;Kenji Nakano;Kenji Nakano;Kenji Nakano;William F. Goins

  • Brain-Specific Angiogenesis Inhibitor-1 Signaling, Regulation and Enrichment in the Postsynaptic Density

    Jason R. Stephenson;Kevin J. Paavola;Stacy A. Schaefer;Balveen Kaur

Frequent Co-Authors

E. Antonio Chiocca
E. Antonio Chiocca Brigham and Women's Hospital
Jianhua Yu
Jianhua Yu City Of Hope National Medical Center
Michael A. Caligiuri
Michael A. Caligiuri City Of Hope National Medical Center
Erwin G. Van Meir
Erwin G. Van Meir University of Alabama at Birmingham
Daniel J. Brat
Daniel J. Brat Northwestern University
Joseph C. Glorioso
Joseph C. Glorioso University of Pittsburgh
William F. Goins
William F. Goins University of Pittsburgh
Michael C. Ostrowski
Michael C. Ostrowski Medical University of South Carolina
Ichiro Nakano
Ichiro Nakano University of Alabama at Birmingham
Carlo M. Croce
Carlo M. Croce The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology in the USA opens doors to diverse career pathways, many of which intersect with the growing fields of psychology, counseling, and human services. Students interested in how biological sciences connect to mental health may consider pursuing child psychology masters programs online. These programs provide insight into how genetics and environment together influence mental development.

For those seeking to lower education costs while branching into allied health fields, exploring the cheapest masters in counseling can be a strategic step. These degrees are invaluable for graduates aiming to support mental wellness while applying molecular biology perspectives.

Students who wish to become licensed psychologists may look into clinical psychologist online programs. Such programs often welcome applicants with science backgrounds and can lead to rewarding roles in research, healthcare, or therapy.

Alternatively, integrating biological sciences with community impact is possible through human services online degree offerings. These flexible options allow you to quickly transition into support, advocacy, or public health roles—complementing a background in molecular biology.

Best Scientists Citing Balveen Kaur

Trending Scientists

Recently Published Articles